The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2545-2553

  Seguín Estévez, Queralt ^a   De Palma, Raffaele ^b   Krawczyk, Michal ^a,g   Leimgruber, Elisa ^a   Villard, Jean ^c   Picard, Capucine ^d   Tagliamacco, Augusto ^e   Abbate, Gianfranco ^b   Gorski, Jack ^f   Nocera, Arcangelo ^e   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITY OF GENOA   (Italy)

^f BLOOD RESEARCH INSTITUTE   (United States)

^g SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; ENHANCEOSOME; GAMMA INTERFERON; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN CIITA; PROTEIN DERIVATIVE; REGULATORY FACTOR X; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HLA D ANTIGEN; HLA DO ANTIGENS; HLA-DO ANTIGENS; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSACTIVATOR PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FIBROBLAST; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; WILD TYPE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; ENHANCER REGION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

B-LYMPHOCYTE SUBSETS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; DNA METHYLATION; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE SILENCING; HLA-D ANTIGENS; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 70149125037     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900376     Document Type: Article

References (61)

1. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19: 331-373. (Pubitemid 32368039)
2. Ting, J. P., and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109(Suppl.): S21-S33.
3. Boss, J. M., and P. E. Jensen. 2003. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15: 105-111.
4. Reith, W., S. LeibundGut-Landmann, and J. M. Waldburger. 2005. Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5: 793-806.
5. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12: 259-293. (Pubitemid 24140416)
6. Busch, R., C. H. Rinderknecht, S. Roh, A. W. Lee, J. J. Harding, T. Burster, T. M. Hornell, and E. D. Mellins. 2005. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207: 242-260.
7. Denzin, L. K., J. L. Fallas, M. Prendes, and W. Yi. 2005. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207: 279-292.
8. Taxman, D. J., D. E. Cressman, and J. P. Ting. 2000. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DNα/DOβ heterodimer. J. Immunol. 165: 1410-1416.
9. Nagarajan, U. M., J. Lochamy, X. Chen, G. W. Beresford, R. Nilsen, P. E. Jensen, and J. M. Boss. 2002. Class II transactivator is required for maximal expression of HLA-DOB in B cells. J. Immunol. 168: 1780-1786.
10. Hake, S. B., H. M. Tobin, V. Steimle, and L. K. Denzin. 2003. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes. Eur. J. Immunol. 33: 2361-2371.
11. Karlsson, L., C. D. Surh, J. Sprent, and P. A. Peterson. 1991. A novel class II MHC molecule with unusual tissue distribution. Nature 351: 485-488. (Pubitemid 21896625)
12. Surh, C. D., E. K. Gao, H. Kosaka, D. Lo, C. Ahn, D. B. Murphy, L. Karlsson, P. Peterson, and J. Sprent. 1992. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176: 495-505.
13. Douek, D. C., and D. M. Altmann. 1997. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9: 355-364.
14. Hornell, T. M., T. Burster, F. L. Jahnsen, A. Pashine, M. T. Ochoa, J. J. Harding, C. Macaubas, A. W. Lee, R. L. Modlin, and E. D. Mellins. 2006. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J. Immunol. 176: 3536-3547.
15. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9: 1021-1032.
16. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16: 1045-1055.
17. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20: 273-277.
18. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10: 153-162.
19. Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10: 143-151.
20. Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15-27.
21. Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269: 20020-20025. (Pubitemid 24250922)
22. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91: 554-558. (Pubitemid 24041440)
23. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155: 4313-4321.
24. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166. (Pubitemid 30324428)
25. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency. Cell 75: 135-146.
26. Zhu, X. S., M. W. Linhoff, G. Li, K. C. Chin, S. N. Maity, and J. P. Ting. 2000. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20: 6051-6061.
27. DeSandro, A. M., U. M. Nagarajan, and J. M. Boss. 2000. Associations and interactions between bare lymphocyte syndrome factors. Mol. Cell. Biol. 20: 6587-6599.
28. Mahanta, S. K., T. Scholl, F. C. Yang, and J. L. Strominger. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94: 6324-6329. (Pubitemid 127650125)
29. Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12: 61-70. (Pubitemid 30069215)
30. Mudhasani, R., and J. D. Fontes. 2002. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 22: 5019-5026.
31. Spilianakis, C., A. Kretsovali, T. Agalioti, T. Makatounakis, D. Thanos, and J. Papamatheakis. 2003. CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II. EMBO J. 22: 5125-5136.
32. Raval, A., T. K. Howcroft, J. D. Weissman, S. Kirshner, X. S. Zhu, K. Yokoyama, J. Ting, and D. S. Singer. 2001. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250. Mol. Cell. 7: 105-115.
33. Zika, E., and J. P. Ting. 2005. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 17: 58-64.
34. Masternak, K., and W. Reith. 2002. Promoter-specific functions of CIITA and the MHC class II enhancesosome in transcriptional activation. EMBO J. 21: 1379-1388.
35. Mudhasani, R., and J. D. Fontes. 2005. Multiple interactions between BRG1 and MHC class II promoter binding proteins. Mol. Immunol. 42: 673-682.
36. Leimgruber, E., Q. Seguin-Estevez, I. Dunand-Sauthier, N. Rybtsova, C. D. Schmid, G. Ambrosini, P. Bucher, and W. Reith. 2009. Nucleosome eviction from MHC class II promoters controls positioning of the transcription start site. Nucleic Acids Res. 37: 2514-2528.
37. Krawczyk, M., E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, E. Barras, and W. Reith. 2007. Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes. Nucleic Acids Res. 35: 595-605.
38. Villard, J., B. Lisowska-Grospierre, P. Van den Elsen, A. Fischer, W. Reith, and B. Mach. 1997. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337: 748-753.
39. Peretti, M., J. Villard, E. Barras, M. Zufferey, and W. Reith. 2001. Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol. Cell. Biol. 21: 5699-5709.
40. Krawczyk, M., K. Masternak, M. Zufferey, E. Barras, and W. Reith. 2005. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study. Mol. Cell. Biol. 25: 8607-8618.
41. Masternak, K., N. Peyraud, M. Krawczyk, E. Barras, and W. Reith. 2003. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4: 132-137.
42. Rybtsova, N., E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, M. Krawczyk, and W. Reith. 2007. Transcription-coupled deposition of histone modifications during MHC class II gene activation. Nucleic Acids Res. 35: 3431-3441.
43. Bontron, S., V. Steimle, C. Ucla, and B. Mach. 1997. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99: 541-546.
44. Nekrep, N., N. Jabrane-Ferrat, H. M. Wolf, M. M. Eibl, M. Geyer, and B. M. Peterlin. 2002. Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome. Nat. Immunol. 3: 1075-1081.
45. Beresford, G. W., and J. M. Boss. 2001. CIITA coordinates multiple histone acetylation modifications at the HLA- DRA promoter. Nat. Immunol. 2: 652-657.
46. Berger, S. L. 2007. The complex language of chromatin regulation during transcription. Nature 447: 407-412.
47. Klose, R. J., and A. P. Bird. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31: 89-97.
48. Martin, C., and Y. Zhang. 2005. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell. Biol. 6: 838-849. (Pubitemid 41568733)
49. Rand, E., I. Ben-Porath, I. Keshet, and H. Cedar. 2004. CTCF elements direct allele-specific undermethylation at the imprinted H19 locus. Curr. Biol. 14: 1007-1012.
50. Mummaneni, P., P. Yates, J. Simpson, J. Rose, and M. S. Turker. 1998. The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res. 26: 5163-5169. (Pubitemid 28517574)
51. Boumber, Y. A., Y. Kondo, X. Chen, L. Shen, Y. Guo, C. Tellez, M. R. Estecio, S. Ahmed, and J. P. Issa. 2008. An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet. 4: e1000162.
52. Yu, Q., V. T. Thieu, and M. H. Kaplan. 2007. Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Rα gene during Th1 differentiation. EMBO J. 26: 2052-2060.
53. Niesen, M. I., A. R. Osborne, H. Yang, S. Rastogi, S. Chellappan, J. Q. Cheng, J. M. Boss, and G. Blanck. 2005. Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX. J. Biol. Chem. 280: 38914-38922.
54. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252: 709-712.
55. Krawczyk, M., Q. Seguin-Estevez, E. Leimgruber, P. Sperisen, C. Schmid, P. Bucher, and W. Reith. 2008. Identification of CIITA regulated genetic module dedicated for antigen presentation. PLoS Genet. 4: e1000058.
56. Jaenisch, R., and A. Bird. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.): 245-254.
57. Kress, C., H. Thomassin, and T. Grange. 2001. Local DNA demethylation in vertebrates: how could it be performed and targeted? FEBS Lett. 494: 135-140.
58. Lopez-Serra, L., and M. Esteller. 2008. Proteins that bind methylated DNA and human cancer: reading the wrong words. Br. J. Cancer 98: 1881-1885.
59. D'Alessio, A. C., and M. Szyf. 2006. Epigenetic tête-á- tête: the bilateral relationship between chromatin modifications and DNA methylation. Biochem. Cell. Biol. 84: 463-476.
60. Trowsdale, J. 1997. MHC. Res. Immunol. 148: 425-426.
61. Chen, X., and P. E. Jensen. 2008. MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes. Exp. Mol. Pathol. 85: 40-44.